NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Sharyle Fowler
University of Saskatchewan - Saskatoon / Canada
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 661134
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sharyle Fowler's MOST POPULAR ARTICLES
1-)
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in PregnancyIBDPCG Nguyen GC, Seow CH, Maxwell CGastroenterology 150 (3), 734-757, 20163802016
2-)
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised …L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ...The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022592022
3-)
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 studyS Danese, JF Colombel, M Lukas, JP Gisbert, G D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Haens, B Hayee, ...The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022592022
4-)
SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn\'s diseaseSA Fowler, AN Ananthakrishnan, A Gardet, CR Stevens, JR Korzenik, ...Journal of Crohn\'s and Colitis 8 (8), 845-851, 2014612014
5-)
Effects of cancer treatment on inflammatory bowel disease remission and reactivationJE Axelrad, SA Fowler, S Friedman, AN Ananthakrishnan, V YajnikClinical Gastroenterology and Hepatology 10 (9), 1021-1027. e1, 2012572012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept